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Lewis and AB0 blood group-
phenotypes in periodontitis, 
cardiovascular disease, obesity and 
stroke
C. Enevold1, C. H. Nielsen1,2, D. Molbo3, R. Lund3, K. Bendtzen1, N. -E. Fiehn4 & p. Holmstrup2
The AB0 blood group has been linked to ischaemic heart disease, stroke, and periodontal disease, 
while the Lewis blood group has been linked to ischaemic heart disease and obesity, all of which have 
been associated with periodontitis. AB0 or Lewis blood group phenotype may therefore constitute 
common hereditary components predisposing to these disorders. In this study, we investigated if 
blood group phenotype associated with periodontitis in a subpopulation consisting of 702 participants 
from a Danish cross-sectional cohort and, secondarily, attempted to confirm their association with 
hypertension, ischaemic heart disease, stroke, and obesity. No significant association between blood 
group phenotype and periodontitis was detected, nor were previously reported associations between 
blood group phenotype and hypertension, ischaemic heart disease, stroke, and obesity confirmed. 
This may, at least partly, be attributed to differences in study type, outcome definitions, cohort sizes, 
and population attributable factors. However, our results suggested a strong association between self-
reported stroke and the Lewis (a−b−) phenotype (P = 0.0002, OR: 22.28; CI 95: 4.72–131.63).
The AB0 and Lewis blood group systems have both been linked to ischaemic heart disease (IHD)1–4. In addition, 
the AB0 blood group has been associated with stroke5, while the Lewis blood group has been associated with 
obesity3. All of these conditions have also been associated with periodontitis (PD)6–8, hence, AB0 and Lewis blood 
groups may constitute common hereditary components behind these disorders.
The AB0 blood group system comprises a major human alloantigen system, the phenotype of which is deter-
mined by three different allelic versions of the AB0 gene located on chromosome 9, giving rise to the four possible 
AB0 blood groups; “A”, “B”, “AB”, and “0”. The AB0 gene encodes a glycosyltransferase that catalyses the transfer 
of oligosaccharide moieties to the common H antigen, thereby forming the antigenic determinants of the A and 
B blood groups9.
The related Lewis blood group system comprises the two Lewis antigens, “Lea” and “Leb” each of which 
can either be present or absent, leading to four possible Lewis phenotypes: Le(a−b−), Le(a+ b−), Le(a−b+), 
and Le(a+ b+)10. Its basis is the fucosyltransferase 3 (FUT3)-encoding Lewis gene that controls formation of 
the Lea-antigen, and the fucosyltransferase 2 (FUT2)-encoding Secretor gene that controls formation of the 
Leb-antigen by converting Lea-antigen into Leb-antigen. FUT2 also controls the expression of AB0-antigens in the 
tissues; in the absence of an active FUT2 gene (non-secretors), no Leb antigen will be formed, and AB0 antigens 
will not be expressed in the tissues11.
The phenotypic distribution of the two alloantigen systems varies tremendously with both geography and eth-
nicity suggesting that it has been subject to selection pressure. Indeed, blood group 0 appears to confer a relative 
resistance to severe malaria, while non-0 subjects appear to have reduced susceptibility to severe infections with 
V. cholera and E. coli12–14. Correspondingly, Lewis blood group phenotype has been associated with susceptibility 
to rotavirus and Helicobacter pylori infection15,16.
1Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, 
Denmark. 2University of Copenhagen, Faculty of Health and Medical Sciences, Department of Odontology, 
Copenhagen, Denmark. 3University of Copenhagen, Faculty of Health and Medical Sciences, Department of Public 
Health, Section of Social Medicine, Copenhagen, Denmark. 4University of Copenhagen, Faculty of Health and 
Medical Sciences, Department of Immunology and Microbiology, Copenhagen, Denmark. Correspondence and 
requests for materials should be addressed to C.E. (email: chrej@hotmail.com)
Received: 28 June 2018
Accepted: 1 April 2019
Published: xx xx xxxx
opeN
2Scientific RepoRts |          (2019) 9:6283  | https://doi.org/10.1038/s41598-019-42594-z
www.nature.com/scientificreportswww.nature.com/scientificreports/
PD is a common disease characterized by chronic inflammation and destruction of the tooth-supporting 
tissues, ultimately leading to tooth loss17. PD can present late in life in a chronic slowly progressive form or, more 
rarely, earlier in life in an aggressive form with rapid tissue deterioration18. The causal and pathogenic differences 
behind these divergent forms of PD remain unclear, but a common denominator is destruction of the periodontal 
tissues, that is believed to be caused by inflammatory processes initiated by bacterial colonization of the tooth 
surfaces19. Approximately half of the adult population above 50 years of age suffer from PD to varying degrees20, 
but the exact prevalence is uncertain due to lack of consensus case criteria21.
The AB0 blood group phenotype has been associated with PD in several studies22–27, but to our knowledge no 
similar studies on Lewis blood group phenotype have yet been published.
In view of the proposed link between blood group phenotypes and ischemic heart disease, stroke, and obesity, 
and between these conditions and PD, we hypothesized that Lewis and AB0 blood groups constitute risk factors 
for PD as well and tested this hypothesis in a Danish cross-sectional cohort. The validity of these investigations 
rest on the assumptions of existing associations between blood group phenotypes and hypertension, ischaemic 
heart disease, stroke, and obesity, hence we attempted to confirm these associations as well.
Results
Demographics. The distribution of the study population exposures and covariables by PD case definitions, 
obesity, IHD, stroke, and hypertension is shown in Table 1.
The age of the participants ranged narrowly between 50 and 61 years, with men comprising the majority of 
the cohort (72%).
In the present cohort, according to the CAL-tertile definition, 197 (28%) participants were defined as perio-
dontitis patients, while 112 (16%) were classified as having severe periodontitis. Severe periodontitis was signif-
icantly associated with IHD (P = 0.03, OR: 4.15; CI 95: 1.17–15.67) but not with obesity, stroke or hypertension 
(data not shown). Periodontitis in general was not significantly associated to any of the conditions studied (data 
not shown).
The average BMI among participants ranged between 17 and 58 with a mean of 26, and 92 participants (13%) 
were classified as obese with a BMI of at least 30. Obesity was significantly associated with diabetes, social class, 
hypertension, CRP-level, triglyceride level, and inversely related to high density lipoprotein level (Table 2).
Nineteen (3%) of the participants had experienced myocardial infarction or angina pectoris, 16 (2%) had 
experienced a stroke, and 275 (39%) had hypertension, either self-reported or according to blood pressure meas-
urements, or use of anti-hypertensive medication. IHD was significantly associated with social class and diabetes, 
and stroke was strongly associated with age, while hypertension was associated with age, social class, obesity and 
CRP-levels (Table 2).
Lewis and AB0 blood group associations. No significant associations were observed between AB0 or 
Lewis blood groups and either of the included definitions of PD.
Although only 16 among the 702 participants had experienced a stroke, a highly significant association to 
the Lewis(a−b−) blood group was observed for this group (P = 0.0002, OR: 22.28; CI 95: 4.72–131.63 - Table 2). 
Among stroke victims, 56% (9 of the 16 participants) carried the Lewis(a−b−) blood group, compared to only 
14% (84 of 686) Lewis(a−b−) among the remaining participants. In contrast, IHD was not reported by any of the 
Lewis(a−b−) participants.
No significant associations were observed between Lewis blood group and hypertension, IHD, or obesity, nor 
were AB0 blood groups significantly associated with any of the investigated parameters (Table 2).
Discussion
We investigated the association of Lewis and AB0 blood groups with PD and sought to confirm previously 
reported associations between blood group phenotype and hypertension, IHD, stroke, and obesity in a subpopu-
lation of the CAMB-cohort consisting of 702 participants. The AB0 blood group has been linked to IHD1, stroke5, 
and periodontal disease22–27, while the Lewis blood group has been linked to IHD2 and obesity3, all of which have 
been associated with PD6–8,28,29. We were not able to confirm any of those relationships, however. Notably, associ-
ations with PD remained non-significant, even though we included two accepted but very different PD definitions 
with widely ranging frequencies (28% vs. 16%, respectively).
By contrast, we observed a strong association between the Lewis(a−b−) phenotype and self-reported 
(non-fatal) stroke incidence: OR (CI 95%) = 22.28 (4.72–131.63). To our knowledge, this has not previously been 
reported, although IHD and ischemic stroke share risk factors and have similar pathophysiologies30.
Besides age and Lewis blood group, none of the included covariables were significantly associated with stroke 
(Table 2), so it does not seem likely that factors that may be associated with ischaemic conditions (e.g. blood 
pressure, diabetes, triglyceride and cholesterol levels) can explain the observed association between Lewis blood 
group and stroke.
Conversely, the relationship between stroke and rheological parameters, particularly plasma viscosity, has 
been shown by others to be at least as strong as its relationship to conventional risk factors such as smoking, blood 
pressure, and cholesterol levels31. Additionally, rheological parameters, including erythrocyte sedimentation rate, 
red blood cell aggregation, and plasma viscosity, have been shown to be markedly aggravated in Le-negative indi-
viduals32. This supports our finding of a significantly increased occurrence of stroke in Le-negative individuals.
Stroke incidence was self-reported, so it cannot be determined whether the stroke(s) were ischaemic or haem-
orrhagic. However, ischaemic stroke is by far (>82%) the more common form33, and this fits well with previously 
reported associations between the Lewis(a−b−) phenotype and ischaemic disease2. Although self-reported diag-
noses may be associated with considerable uncertainty depending on survey method, participant characteristics, 
and reference standard used34, acceptable error rates have been observed in health surveys comparable to ours35.
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It should be noted that this study was cross-sectional without the possibility of following participants pro-
spectively. Hence, only non-fatal IHD and stroke reports were included. In another Danish cross-sectional study, 
the rate of fatal strokes among all strokes observed was estimated to be 19%36. Interestingly, there was no overlap 
between participants reporting a history of stroke and those reporting a history of IHD in this study. Based on 










All (N (%)) 702 (100) 112 (16) 197 (28) 275 (39) 19 (3) 16 (2) 92 (13)
Age (mean (SD))
    Years 55 (3) 56 (3) 55 (3) 55 (3) 55 (3) 57 (3) 55 (3)
Gender (N (%))
    Men 504 (72) 90 (18) 160 (32) 223 (44) 17 (3) 10 (2) 77 (15)
    Women 198 (28) 22 (11) 37 (19) 52 (26) 2 (1) 6 (3) 15 (8)
Smoking (N (%))
    Never 254 (36) 17 (7) 32 (13) 87 (34) 4 (2) 6 (2) 36 (14)
    Previous 288 (41) 43 (15) 85 (30) 124 (43) 3 (1) 7 (2) 37 (13)
    Present 160 (23) 52 (33) 80 (50) 64 (40) 12 (8) 3 (2) 19 (12)
Alcohol, drinks per week (N (%))
    None 72 (10) 10 (14) 23 (32) 28 (39) 4 (6) 3 (4) 11 (15)
    1–7 (women)/1–14 (men) 376 (54) 59 (16) 101 (27) 145 (39) 7 (2) 7 (2) 46 (12)
    8–14 (women)/15–21 (men) 125 (18) 17 (14) 31 (25) 40 (32) 1 (1) 1 (1) 15 (12)
    >14 (women)/>21 (men) 129 (18) 26 (20) 42 (33) 62 (48) 7 (5) 5 (4) 20 (16)
Diabetes (N (%))
    No (HbA1c <6.5%) 667 (95) 104 (16) 181 (27) 251 (38) 14 (2) 16 (2) 77 (12)
    Yes (HbA1c≥6.5%) 35 (5) 8 (23) 16 (46) 24 (69) 5 (14) 0 (0) 15 (43)
Social Class (N (%))
    Social class I 71 (10) 11 (15) 15 (21) 26 (37) 0 (0) 2 (3) 8 (11)
    Social class II 227 (32) 31 (14) 55 (24) 74 (33) 6 (3) 4 (2) 21 (9)
    Social class III 187 (27) 28 (15) 56 (30) 78 (42) 5 (3) 4 (2) 25 (13)
    Social class IV 123 (18) 22 (18) 40 (33) 50 (41) 0 (0) 3 (2) 21 (17)
    Social class V 41 (6) 9 (22) 12 (29) 21 (51) 2 (5) 0 (0) 7 (17)
    Transfer income 53 (8) 11 (21) 19 (36) 26 (49) 6 (11) 3 (6) 10 (19)
Body Mass Index (mean (SD))
    Weight/height2 26 (4) 27 (5) 27 (4) 27 (4) 27 (3) 26 (4) 33 (4)
AB0 bloodtype (N (%))
    0 271 (39) 47 (17) 78 (29) 101 (37) 6 (2) 6 (2) 35 (13)
    A 308 (44) 46 (15) 77 (25) 123 (45) 9 (3) 7 (2) 40 (13)
    B 97 (14) 11 (11) 34 (35) 42 (43) 4 (4) 3 (3) 15 (15)
    AB 26 (4) 8 (31) 8 (31) 9 (35) 0 (0) 0 (0) 2 (8)
Lewis bloodtype (N (%))
    a−b− 93 (13) 18 (19) 29 (31) 30 (32) 0 (0) 9 (10) 10 (11)
    a−b+ 481 (69) 79 (16) 142 (30) 187 (39) 14 (3) 5 (1) 62 (13)
    a + b− 127 (18) 15 (12) 26 (20) 58 (46) 5 (4) 2 (2) 20 (16)
    a + b+ 1 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Clinical attachment level (mean (SD)), mm 2.39 (0.61) 3.29 (0.99) 3.04 (0.82) 2.47 (0.74) 2.76 (0.67) 2.31 (0.30) 2.47 (0.62)
Diastolic blood pressure (mean (SD)), mmHg 88 (10) 88 (9) 89 (10) 95 (9) 87 (10) 87 (9) 93 (9)
Systolic blood pressure (mean (SD)), mmHg 136 (17) 136 (17) 138 (17) 149 (17) 134 (11) 133 (14) 145 (17)
Cholesterol (mean (SD)), mmol/l 5.36 (0.82) 5.35 (0.90) 5.33 (0.87) 5.40 (0.84) 4.97 (0.85) 4.76 (0.71) 5.40 (0.81)
High sensitivity-CRP (mean (SD)), mg/l 1.92 (3.45) 2.30 (2.87) 2.18 (2.82) 2.52 (4.67) 1.62 (1.68) 2.37 (4.73) 4.57 (7.11)
Low-density lipoprotein (mean (SD)), mg/l 2.77 (0.72) 2.75 (0.74) 2.74 (0.80) 2.81 (0.74) 2.46 (0.79) 2.12 (0.79) 2.82 (0.72)
High-density lipoprotein (mean (SD)), mg/l 1.46 (0.38) 1.37 (0.36) 1.36 (0.36) 1.40 (0.36) 1.28 (0.32) 1.44 (0.26) 1.23 (0.31)
Triglycerides (mean (SD)), mg/l 1.80 (1.05) 2.08 (1.18) 2.06 (1.31) 2.05 (1.18) 2.12 (1.02) 1.87 (2.13) 2.61 (1.35)
Table 1. Distribution of study population exposure- and covariables by periodontitis case definitions, 
obesity, ischaemic heart disease, stroke, and hypertension. CAL-tertile; Clinical Attachment Level-tertile case 
criterium(REF). BMI; Body Mass Index (defined as weight (kg)/height squared (m2)), IHD; Ischaemic Heart 
Disease (self-reported), Stroke; self-reported stroke, Hypertension; self-reported or measured hypertension 
(diastolic pressure ≥ 100 mmHg or systolic pressure ≥ 150 mmHg).
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expected in the IHD group. A possible explanation for this observation could be that there is an increased inci-
dence of fatal IHD among Lewis(a−b−) subjects, as has been reported previously2. Given the cross-sectional 
nature of our study in combination with the relatively low number of participants reporting IHD, it seems likely 
that IHD-events among potential Lewis(a−b−) participants could have been fatal. Moreover, cerebral ischemia 
has previously been associated with asymptomatic IHD and increased risks of fatal IHD following stroke has been 
reported37.
Unexpectedly, we did not observe significant associations between age and IHD, nor between age and obesity 
in this cohort. These observations may be attributed to the skewed and very narrowly ranged age distribution 
within the cohort, possibly in combination with a pronounced overrepresentation of male participants.
It should also be taken into account that PD, obesity, IHD, stroke, and hypertension are all complex conditions 
that are under the influence of numerous parameters such as medication and general lifestyle factors like diet and 
excercise.
In conclusion, the results of the present study do not support the hypothesis of a role for Lewis or AB0 blood 
groups in PD, nor were previously reported associations between blood group phenotype and hypertension, 
ischaemic heart disease, stroke, and obesity confirmed. This may, at least partly, be attributable to differences 
in study type, outcome definitions, cohort sizes, and population attributable factors. As a secondary observa-
tion, however, our results indicate a strong association between the Lewis(a−b−) phenotype and self-reported 
(non-fatal) stroke incidence, which warrants further investigations.
Materials and Methods
Study population. Study participants comprised a subpopulation from the Copenhagen Aging and Midlife 
Biobank (CAMB) whose oral health was assessed during the establishment of CAMB in 2009–201138. Briefly, 
CAMB is a merger of three established cohorts: The Metropolit Cohort (10,171 men born in Copenhagen in 
1953, age at follow-up 56–58), The Copenhagen Perinatal Cohort (8,102 men and women born at the National 
University Hospital in Copenhagen in 1959–1961, age at follow-up 49–52), and the Danish Longitudinal Study 
on Work, Unemployment, and Health (11,082 men and women, born 1949 and 1959, constituting a random sam-
ple of the Danish population in 1999, age at follow-up 50–53 and 60–63. 17,937 eligible persons from the three 
established cohorts living in the Eastern parts of Denmark were invited to participate and of these, 5,575 came to 
a study clinic for further testing and blood sampling. A total of 1,517 participants from this group took part in The 
CAMB Oral Health Study as described previously39. Of these, 702 had complete registrations for all of the selected 
exposures and covariables as well as blood samples forming the basis of the present study.









Blood group A positive 1.26 (0.73–2.16) 0.66 (0.42–1.02) 1.08 (0.76–1.53) 0.70 (0.19–2.37) 0.35 (0.06–1.61) 0.85 (0.48–1.47)
Blood group B positive 0.70 (0.35–1.35) 1.25 (0.74–2.10) 0.98 (0.63–1.53) 0.86 (0.19–3.24) 0.53 (0.06–2.98) 0.72 (0.35–1.42)
Lewis negative (a−b−) 1.40 (0.67–2.86) 1.42 (0.75–2.64) 0.69 (0.4–1.14) N.A. 22.28 (4.72–131.63) 0.77 (0.32–1.70)
Age (decades) 2.77 (1.13–6.86) 2.01 (0.98–4.12) 2.69 (1.53–4.78) 0.95 (0.09–10.02) 37.04 (4.94–446.68) 1.71 (0.68–4.29)
Gender (Men) 0.69 (0.34–1.42) 1.39 (0.78–2.49) 1.29 (0.82–2.04) 2.58 (0.38–26.56) 0.63 (0.15–3.02) 0.90 (0.43–1.99)
Previous smoking 1.50 (0.77–3.00) 2.60 (1.57–4.40) 1.31 (0.89–1.92) 0.38 (0.06–2.08) 1.87 (0.45–9.01) 0.68 (0.38–1.22)
Present smoking 2.99 (1.47–6.23) 4.92 (2.76–8.92) 1.06 (0.65–1.72) 2.87 (0.65–14.77) 1.52 (0.19–11.11) 0.37 (0.16–0.81)
Alcohol abstaining 0.43 (0.16–1.06) 1.22 (0.60–2.41) 0.95 (0.52–1.7) 1.39 (0.25–6.66) 3.60 (0.47–23.83) 0.99 (0.39–2.33)
Drinks per week: 8–14 (women)/15–21 (men) 0.76 (0.36–1.53) 1.04 (0.58–1.83) 0.8 (0.5–1.28) 0.56 (0.03–4.00) 0.40 (0.02–3.03) 1.16 (0.54–2.36)
Drinks per week: >14 (women)/>21 (men) 1.08 (0.54–2.09) 1.04 (0.58–1.82) 1.27 (0.81–2) 3.47 (0.81–15.83) 2.50 (0.52–11.51) 1.21 (0.59–2.45)
Social class I 1.90 (0.73–4.75) 0.97 (0.42–2.12) 1.43 (0.78–2.61) N.A. 1.54 (0.13–12.83) 1.95 (0.70–5.10)
Social class III 0.89 (0.45–1.74) 1.39 (0.82–2.38) 1.43 (0.93–2.2) 0.99 (0.23–4.20) 0.89 (0.14–5.53) 1.73 (0.86–3.55)
Social class IV 1.06 (0.50–2.22) 1.47 (0.80–2.67) 1.34 (0.82–2.19) N.A. 0.78 (0.09–5.33) 2.39 (1.10–5.20)
Social class V 1.70 (0.56–4.83) 1.03 (0.39–2.59) 2.37 (1.14–4.99) 3.82 (0.43–27.12) N.A. 2.50 (0.82–7.06)
Transfer income 1.17 (0.41–3.18) 1.09 (0.46–2.48) 1.66 (0.83–3.31) 5.65 (1.18–28.90) 5.84 (0.57–59.96) 1.58 (0.53–4.36)
Diabetes (HbA1c ≥ 6.5%) 0.67 (0.21–1.99) 1.58 (0.62–3.90) 2.07 (0.92–4.85) 7.09 (1.31–40.35) N.A. 3.36 (1.38–8.10)
Cholesterol (mmol/l) 1.27 (0.63–2.55) 0.99 (0.56–1.73) 0.94 (0.6–1.47) 0.90 (0.15–4.49) 0.76 (0.10–5.04) 1.02 (0.49–2.08)
High sensitivity-C-reactive protein (mg/l) 1.01 (0.92–1.07) 0.99 (0.92–1.05) 1.07 (1.01–1.14) 0.85 (0.57–1.07) 0.91 (0.73–1.08) 1.22 (1.13–1.31)
Low density-lipoprotein (mmol/l) 0.72 (0.34–1.51) 0.92 (0.50–1.68) 1.1 (0.68–1.79) 0.68 (0.12–3.91) 0.20 (0.02–1.61) 1.16 (0.53–2.53)
High density-lipoprotein (mmol/l) 0.64 (0.24–1.67) 0.62 (0.28–1.38) 0.93 (0.49–1.73) 0.35 (0.03–4.22) 1.23 (0.10–11.52) 0.28 (0.09–0.84)
Triglyceride (mmol/l) 1.04 (0.78–1.39) 1.05 (0.82–1.34) 1.22 (0.99–1.51) 0.75 (0.35–1.55) 1.22 (0.58–2.62) 1.46 (1.10–1.95)
Table 2. Multivariable logistic regression analyses with periodontitis case definitions, obesity, ischemic heart 
disease, stroke, and hypertension as outcomes. CAL-tertile; Clinical Attachment Level-tertile case criterium 
(REF). BMI; Body Mass Index (defined as weight (kg)/height squared (m2)), IHD; Ischaemic Heart Disease; 
Hypertension; self-reported or measured hypertension (diastolic pressure ≥ 100 mmHg or systolic pressure 
≥ 150 mmHg), Actual ages were divided by ten (decades). OR; Odds ratio, CI 95%; 95% confidence interval. 
Statistically significant associations are marked in bold (P ≤ 0.05).
5Scientific RepoRts |          (2019) 9:6283  | https://doi.org/10.1038/s41598-019-42594-z
www.nature.com/scientificreportswww.nature.com/scientificreports/
Covariables. Of the 702 participants with complete data, 504 (72%) were men. Age at the time of inclusion 
ranged from 50 to 61 years, with a mean of 55. Smoking status was included as three categories (never, previous, 
and present smoker). Weekly alcohol consumption was included using the categorization employed by the Danish 
Health Authorities: 0 drinks per week, 1–7 drinks per week (women)/1–14 drinks per week (men), 8–14 drinks 
per week (women)/15–21 drinks per week (men), and >14 drinks per week (women)/>21 drinks per week 
(men), based on a standard Danish drink definition equalling 12 g of pure alcohol. Diabetes diagnosis was based 
on increased haemoglobin A1c levels (≥6.5%), a self-reported diabetes diagnosis, or both. Social class was classi-
fied by occupation and coded into Social Classes I–VIII, according to the standards of the Danish Occupational 
Social Class classification40. According to this classification, Social Classes I–V encompass economically active 
individuals ranging from professional occupation in Social Class I to unskilled occupation in Social Class V. 
Social classes VI–VIII represent people on transfer income, students, homemakers, and those with no informa-
tion on social class. In the present study, we combined class VI–VIII into one. Body Mass Index (BMI) (defined as 
weight (kg)/height squared (m2)) was included as a continuous variable. Blood pressure was recorded in mm Hg 
and reported as the mean of two subsequent measurements. Cholesterol, lipoprotein and triglyceride levels were 
included as continuous variables (Table 1).
Case definitions. Oral examinations were carried out by two trained dental hygienists who followed a stand-
ardized examination protocol performed in fully equipped, stationary dental clinics that included air syringes, 
suction, and overhead lights. Each examiner used a front-surface dental mirror, caries explorer and periodontal 
probe. Re-examinations were not performed due to time constraints. Data were recorded on paper examination 
forms by trained recorders and subsequently entered into an electronic database39.
Large discrepancies in e.g. PD frequency may arise depending on the choice of PD case definition, of which 
several exist. To accommodate this, we included two definitions assumed to broadly represent most of the 
variation between different PD case definitions applied in previous publications; The ‘severe PD’-definition, 
comprising individuals with at least two interproximal sites on different teeth with a minimum CAL of six mil-
limeters, as well as at least one interproximal site with a pocket depth of five millimeters or more41, and the 
‘CAL-tertile’-definition, comprising individuals with a minimum CAL of three millimeters on at least one third 
of their measurement sites42.
Obesity was defined as a BMI of at least 30 kg/m2.
Ischaemic heart disease (IHD) was included as a binary variable defined as a self-reported previous incidence 
of myocardial infarction or angina pectoris.
Stroke was included as a binary variable and defined as a self-reported previous incidence of stroke.
Hypertension was included as a binary variable defined by self-reported hypertension, self-reported use of 
anti-hypertensive medicine, a measured systolic blood pressure of at least 150 mm Hg, or a measured diastolic 
blood pressure of at least 100 mm Hg.
Lewis and AB0 blood group typing. Lewis blood group typing was performed as described by the vendor 
(Biotest AG, Dreieich, Germany). Briefly, 100 microliters of fresh anti-coagulated venous blood were washed in a 
clear Falcon tube (VWR International A/S, Soeborg, Denmark) by the addition of 1 ml of Dulbecco’s phosphate 
buffered saline (PBS) (Life Technologies Europe BV, Naerum, Denmark) followed by a brief centrifugation at 
900 g to pellet blood cells. The supernatant was discarded, and the procedure was repeated until the supernatant 
remained clear. One microliter of the washed blood cells was transferred to each of two clear Falcon tubes con-
taining 39 microliters of PBS, and 40 microliters of either Seraclone anti-Lea or Seraclone anti-Leb (Biotest AG, 
Dreieich, Germany) were added to the suspensions. The tubes were incubated for 15 minutes at ambient temper-
ature and centrifuged briefly at 800 g. Finally, agglutination was assessed visually after gently loosening the pellet.
AB0 blood group typing was performed as described by the vendor (Biotest AG, Dreieich, Germany). 
Briefly, 100 microliter aliquots of test serum were placed in clear Falcon tubes and added 50 microliters of either 
Biotestcell antigen A1, A2, B, or 0. After careful mixing, samples were incubated 15–30 minutes at ambient tem-
perature and centrifuged at 150 g for 2 minutes. Pellets were subsequently loosened and assessed for agglutination.
All blood group typings were performed blinded and by the same technician.
Ethical approval and informed consent. The study was approved by The Ethics Committee for The 
Capital Region of Denmark (#H-A-2008-126). The study was carried out in accordance with relevant guidelines 
and regulations. Informed consent was obtained from all participants.
Statistical analyses. Numerical variables were expressed as means with standard deviations (SD). 
Categorical variables were expressed as numbers (n) with percentages (%). Covariable-adjusted logistic regres-
sion analyses were applied to assess cross-sectional relationships between Lewis- and AB0-blood type and PD, 
hypertension, IHD, stroke, and obesity. Analysis results were expressed as odds ratios (OR) with 95% confidence 
intervals (CI 95%). Two-tailed P < 0.05 was considered statistically significant. Reference categories were cho-
sen by biological relevance as well as population incidence. All analyses were performed in RStudio Version 
1.0.153 (RStudio Inc., Boston, MA, USA) using R version 3.4.2 (R Foundation for Statistical Computing, Vienna, 
Austria).
Data Availability
The data that support the findings of this study are available from The Copenhagen Aging and Midlife Biobank, 
but restrictions apply to the availability of these data, which were used under license for the current study, and so 
are not publicly available. However, data are available from the authors upon reasonable request and with permis-
sion of The Copenhagen Aging and Midlife Biobank steering committee.
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